Xiqing Luo

Dr. Xiqing Luo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2026 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
JLJinwei Li
Jinwei Li
XWXianghui Wen
Xianghui Wen
JZJiaoshi Zhao
Jiaoshi Zhao
MGMin Gao
Min Gao
XHXubin Hao
Xubin Hao
JGJieruo Gu
Jieruo Gu

21 July 2025 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
XYXinyu Yu
Xinyu Yu
DLDong Liu
Dong Liu
XLXiqing Luo
Xiqing Luo
XWXianghui Wen
Xianghui Wen
ZCZena Chen
Zena Chen
JGJieruo Gu
Jieruo Gu

14 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
XLXiqing Luo
Xiqing Luo
XZXuqi Zheng
Xuqi Zheng
WXWenyu Xu
Wenyu Xu
DGDan Guo
Dan Guo
XJXinlei Jia
Xinlei Jia
YJYutong Jiang
Yutong Jiang
Objectives: We tested whether a database-derived phthalate ester (PAE)–ankylosing spondylitis (AS) candidate panel identifies an inflammatory transcriptional program and characterized its transcription-factor (TF) architecture. Methods: Machine learning prioritization and repeated nested cross-validation were followed by locked-model transfer from GSE73754 to GSE25101. Donor-level single-cell analyses included 96,746 peripheral blood mononuclear cells from 10 AS and 29 healthy-control donors (GSE194315), with corroboration assessed in 25 additional baseline AS patients (GSE277117). Results: Within classical monocytes, the continuous signature covaried with panel-excluded TNF-α/NF-κB signaling (ρ = 0.571; q = 0.000729), inflammatory response (ρ = 0.447; q = 0.0108), and eight of 10 AP-1-related TF activities. Target-excluded TF activities covaried with CXCL8 (8/10) and IL1B (10/10). AP-1-gene/CXCL8 co-expression received partial corroboration in the additional AS cohort (JUN–CXCL8: ρ = 0.92). Among 16 genes prioritized from 473 shared candidates, CXCL8, IL2RB, STAT5B and TNF were stable. The locked 14-gene model achieved an area under the receiver-operating-characteristic curve of 0.770 (DeLong 95% confidence interval, 0.596–0.943), supporting partial rank transportability. Secondary analyses showed a lower CD56bright fraction among natural killer (NK) cells in AS (−2.699 percentage points; 95% confidence interval, −4.575 to −0.611; q = 0.0498) and reduced NK-cell JUN expression (log2 fold change = −0.995; adjusted p = 0.0497). Conclusions: The PAE–AS signature identifies an AP-1/CXCL8-associated classical-monocyte inflammatory program, with partial cross-cohort corroboration and secondary NK alterations, providing candidates for exposure-informed mechanistic studies.